<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Sciele Pharma Inc. | Company News & Executive Profiles - SCRX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/sciele+pharma+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Sciele Pharma Inc.]]></description>
	<s:counts start="0" returned="9" found="9" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Shionogi Completes Acquisition of Sciele]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_9/ai_n30885281]]></link>
		<description><![CDATA[OSAKA, Japan & ATLANTA -- On October 9, 2008, Shionogi & Co., Ltd. ("Shionogi") and Sciele Pharma, Inc. ("Sciele") (NASDAQ: SCRX) announced the completion of Shionogi's acquisition of Sciele for US$31.00 per share in cash. Shionogi completed the acquisition through a cash tender offer followed by short-form merger of the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 09 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/advisor.html"><![CDATA[advisor]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merger.html"><![CDATA[merger]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[women]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="tickers">NDAQ,SCRX</category>
	</item>
	<item>
		<title><![CDATA[Underdog Smallcaps: Potential Short Squeezes]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F95295-underdog-smallcaps-potential-short-squeezes%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[J Clinton Hill submits: Most bullies like to pick on smaller guys who often can do little to resist their sheer size and brute strength. The market is no exception and its bullies are the hedge funds and professional traders who typically "gang up" against smallcap stocks.  Yet, as...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 14 Sep 2008 12:26:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/allis-chalmers+energy+inc..html"><![CDATA[Allis-Chalmers Energy Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/americangreetings.html"><![CDATA[AmericanGreetings]]></category>
		<category domain="http://resources.bnet.com/topic/avista+corp..html"><![CDATA[Avista Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/beacon+roofing+supply+inc..html"><![CDATA[Beacon Roofing Supply Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cubist+pharmaceuticals+inc..html"><![CDATA[Cubist Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/calgon+carbon+corp..html"><![CDATA[Calgon Carbon Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/china+security+%2526+surveillance+technology+inc..html"><![CDATA[China Security & Surveillance Technology Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/daktronics+inc..html"><![CDATA[Daktronics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fred%2527s+inc..html"><![CDATA[Fred's Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/idacorp+inc..html"><![CDATA[Idacorp Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/intermec+inc..html"><![CDATA[Intermec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/microsemi+corp..html"><![CDATA[Microsemi Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/netflix+inc..html"><![CDATA[NetFlix Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/premiere+global+services+inc..html"><![CDATA[Premiere Global Services Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/psychiatric+solutions+inc..html"><![CDATA[Psychiatric Solutions Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/red+hat+inc..html"><![CDATA[Red Hat Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/unisource+energy+corp..html"><![CDATA[UniSource Energy Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/encore+wire+corp..html"><![CDATA[Encore Wire Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AVA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BECN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CSR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBST</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DAKT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WIRE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRED</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IDA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MSCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NFLX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PGI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PSYS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RHT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">UNS</category>
		<category domain="tickers">ALY,AM,AVA,BECN,CCC,CSR,CBST,DAKT,WIRE,FRED,IDA,IN,MSCC,NFLX,PGI,PSYS,RHT,SCRX,UNS</category>
	</item>
	<item>
		<title><![CDATA[Eli Lilly's Brewing Battle With Bristol-Myers]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F94230-eli-lilly-s-brewing-battle-with-bristol-myers%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Last week I blogged about Eli Lilly's LLY "Coming Soon" banner ad I spotted in the online edition of The New England Journal of Medicine. It's designed to generate buzz about the company's crucial new bloodthinner that could win Food and Drug Administration approval this month....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 07 Sep 2008 02:11:22 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="tickers">AMLN,BMY,LLY,SCRX</category>
	</item>
	<item>
		<title><![CDATA[Has Lilly's Effient Been FDA Approved?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F93643-has-lilly-s-effient-been-fda-approved%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  I'm not gonna blog about the new Vytorin studies as there's been a plethora of coverage all over, including on CNBC.  The only thing I wanted to mention was that while I was on the New England Journal of Medicine Web site on Monday preparing...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 03 Sep 2008 12:33:28 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="tickers">LLY,SCRX</category>
	</item>
	<item>
		<title><![CDATA[Pharma Merger: Japan?s Shionogi Buys Atlanta's Sciele for $1.42 Billion]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F93523-pharma-merger-japans-shionogi-buys-atlanta-s-sciele-for-1-42-billion%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ron Haruni submits: Shionogi & Co. (SGIOF.PK), a major Japanese drug manufacturer and US-based specialty pharmaceutical company Sciele Pharma, Inc. SCRX, announced on Monday a definitive agreement under which Shionogi will acquire Atlanta-based Sciele Pharma Inc. shares, in an all-cash deal valued at $1.42 billion.  The acquisition on the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 02 Sep 2008 04:39:55 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/japan.html"><![CDATA[Japan]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="tickers">SCRX</category>
	</item>
	<item>
		<title><![CDATA[Sciele Pharma Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-225019.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operators Instructions. Our first question this afternoon will come from Donald Ellis with Thomas Weisel Partners. Donald Ellis - Thomas Weisel Partners Thank you and good afternoon guys. Darrell I just wanted to kind of reconcile the old versus new guidance and the way I'd...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 30 Jul 2008 18:51:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="tickers">SCRX</category>
	</item>
	<item>
		<title><![CDATA[Sciele Pharma, Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-227715.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you.  Operator Instructions.  And, we will go first to Donald Ellis with Thomas Weisel Partners. Donald Ellis Good afternoon guys.  I have a few questions.  First for, I guess are on Sular.  Can you just kind of give us an update...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 30 Apr 2008 17:02:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="tickers">SCRX</category>
	</item>
	<item>
		<title><![CDATA[Sciele Pharma Inc. Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229359.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions  And we will go first to Annabel Samimy - UBS. Annabel Samimy - UBS  On the Sular, have you started drawing down inventories before January?  It seems like the cardiovascular was a little bit lighter than we would have expected....]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 07 Mar 2008 10:42:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="tickers">SCRX</category>
	</item>
	<item>
		<title><![CDATA[Sciele Pharma Q3 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-232327.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. We'll go first to Adam Greene, JP Morgan. Adam Greene - JP Morgan Good evening, everyone. Darrell Borne Hi Adam, how are you? Adam Greene - JP Morgan Good. Few questions for you Darrell, on the guidance, you mentioned the excluding one time charges for...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 30 Oct 2007 18:47:01 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/sciele+pharma+inc..html"><![CDATA[Sciele Pharma Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SCRX</category>
		<category domain="tickers">SCRX</category>
	</item>
</channel>
</rss>
